Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Morgan Stanley Maintains Equal-Weight on Marvell Technology, Raises Price Target to $63

Morgan Stanley analyst Joseph Moore maintains Marvell Technology (NASDAQ:MRVL) with a Equal-Weight and raises the price target from $61 to $63.
byBenzinga Newsdesk
October 7, 2021
1 minute read
Total
0
Shares
0
0
0
0
0
0

Morgan Stanley analyst Joseph Moore maintains Marvell Technology (NASDAQ:MRVL) with a Equal-Weight and raises the price target from $61 to $63.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

4D Molecular Therapeutics Early Sunday Highlighted Presentation Of Interim Results From Ongoing 4D-125 Phase 1/2 Trial In Patients With Advanced X-Linked Retinitis Pigmentosa At American Society Of Retina Specialists Meeting

By Benzinga Newsdesk
October 11, 10:24 AM
4D-125 was well tolerated in all patients treated to-date (n=8), with no dose-limiting toxicities, no serious adverse events and no chronic inflammation   Clinical activity observed through anatomical

FDMT